| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 701.381 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 490.691 | 91 |
| GSM780709 | Untreated after 4 days (C3_1) | 413.42 | 90 |
| GSM780719 | Untreated after 4 days (C1_2) | 701.381 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 537.181 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 428.045 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 504.199 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 611.795 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 856.359 | 95 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 527.073 | 92 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 715.352 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1027.77 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 696.055 | 94 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 591.591 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 803.245 | 94 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 762.316 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 626.985 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 740.595 | 94 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 635.896 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 646.077 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 655.041 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 699.072 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 686.974 | 94 |